Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Ischemia | 4 | 2022 | 278 | 2.320 |
Why?
|
| Stroke | 6 | 2022 | 1075 | 2.170 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2018 | 121 | 1.100 |
Why?
|
| Cerebral Hemorrhage | 4 | 2021 | 154 | 1.050 |
Why?
|
| Hematoma | 3 | 2020 | 94 | 0.920 |
Why?
|
| Anticoagulants | 2 | 2021 | 604 | 0.870 |
Why?
|
| Brain Edema | 2 | 2021 | 71 | 0.830 |
Why?
|
| Space Flight | 3 | 2020 | 169 | 0.770 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 2020 | 71 | 0.760 |
Why?
|
| Diuretics, Osmotic | 1 | 2021 | 4 | 0.730 |
Why?
|
| Atrial Fibrillation | 2 | 2021 | 695 | 0.720 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2021 | 21 | 0.720 |
Why?
|
| Mannitol | 1 | 2021 | 49 | 0.720 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2021 | 285 | 0.700 |
Why?
|
| Glasgow Coma Scale | 2 | 2020 | 200 | 0.640 |
Why?
|
| Common Data Elements | 1 | 2019 | 6 | 0.640 |
Why?
|
| Neurology | 1 | 2021 | 121 | 0.620 |
Why?
|
| Aneurysm, Ruptured | 1 | 2019 | 36 | 0.620 |
Why?
|
| Fibrinolytic Agents | 1 | 2018 | 203 | 0.520 |
Why?
|
| Thrombolytic Therapy | 1 | 2018 | 211 | 0.520 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2021 | 295 | 0.520 |
Why?
|
| Time-to-Treatment | 1 | 2018 | 203 | 0.520 |
Why?
|
| Secondary Prevention | 1 | 2016 | 225 | 0.470 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 894 | 0.420 |
Why?
|
| Thrombectomy | 2 | 2021 | 107 | 0.330 |
Why?
|
| Safe Sex | 1 | 2009 | 16 | 0.320 |
Why?
|
| Condoms | 1 | 2009 | 51 | 0.320 |
Why?
|
| Adaptation, Physiological | 3 | 2020 | 289 | 0.320 |
Why?
|
| Sexual Partners | 1 | 2009 | 87 | 0.310 |
Why?
|
| Object Attachment | 1 | 2009 | 52 | 0.310 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2009 | 98 | 0.300 |
Why?
|
| History, 20th Century | 2 | 2021 | 395 | 0.290 |
Why?
|
| Intracranial Pressure | 2 | 2019 | 212 | 0.260 |
Why?
|
| Blood Pressure | 3 | 2020 | 1421 | 0.250 |
Why?
|
| Humans | 18 | 2022 | 134032 | 0.210 |
Why?
|
| Checklist | 1 | 2022 | 95 | 0.190 |
Why?
|
| Middle Aged | 8 | 2022 | 29393 | 0.180 |
Why?
|
| History, 18th Century | 1 | 2021 | 71 | 0.180 |
Why?
|
| History, 19th Century | 1 | 2021 | 120 | 0.170 |
Why?
|
| Treatment Outcome | 3 | 2021 | 13050 | 0.170 |
Why?
|
| Vasospasm, Intracranial | 1 | 2020 | 19 | 0.170 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 198 | 0.160 |
Why?
|
| Risk Factors | 5 | 2021 | 11162 | 0.160 |
Why?
|
| Vasoconstriction | 1 | 2020 | 102 | 0.160 |
Why?
|
| National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2019 | 12 | 0.160 |
Why?
|
| National Library of Medicine (U.S.) | 1 | 2019 | 5 | 0.160 |
Why?
|
| Brain | 3 | 2020 | 3228 | 0.160 |
Why?
|
| Risk Assessment | 2 | 2021 | 3732 | 0.150 |
Why?
|
| Hyponatremia | 1 | 2020 | 76 | 0.150 |
Why?
|
| Astronauts | 1 | 2019 | 76 | 0.150 |
Why?
|
| Vision, Ocular | 1 | 2019 | 133 | 0.150 |
Why?
|
| Sodium | 1 | 2020 | 309 | 0.150 |
Why?
|
| Magnesium | 1 | 2019 | 127 | 0.150 |
Why?
|
| Intracranial Aneurysm | 1 | 2019 | 84 | 0.150 |
Why?
|
| Texas | 3 | 2020 | 3713 | 0.150 |
Why?
|
| Cost Savings | 1 | 2018 | 75 | 0.140 |
Why?
|
| Single-Blind Method | 1 | 2018 | 250 | 0.140 |
Why?
|
| Spectrum Analysis | 1 | 2018 | 69 | 0.140 |
Why?
|
| Neurophysiological Monitoring | 1 | 2018 | 38 | 0.140 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 757 | 0.130 |
Why?
|
| Quality Improvement | 1 | 2022 | 701 | 0.130 |
Why?
|
| Aged | 6 | 2021 | 21750 | 0.130 |
Why?
|
| Prognosis | 3 | 2020 | 5081 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 1218 | 0.120 |
Why?
|
| Retrospective Studies | 5 | 2021 | 17507 | 0.120 |
Why?
|
| Warfarin | 1 | 2016 | 125 | 0.120 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2015 | 119 | 0.120 |
Why?
|
| Hospital Mortality | 1 | 2020 | 1095 | 0.110 |
Why?
|
| Stents | 1 | 2021 | 877 | 0.110 |
Why?
|
| Intracranial Hypertension | 1 | 2015 | 134 | 0.110 |
Why?
|
| Hospitalization | 1 | 2022 | 1901 | 0.110 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 563 | 0.110 |
Why?
|
| Patient Education as Topic | 1 | 2016 | 468 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2019 | 556 | 0.100 |
Why?
|
| Male | 8 | 2021 | 66022 | 0.090 |
Why?
|
| Endarterectomy, Carotid | 1 | 2012 | 95 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 413 | 0.090 |
Why?
|
| Carotid Stenosis | 1 | 2012 | 135 | 0.090 |
Why?
|
| Female | 8 | 2021 | 71818 | 0.090 |
Why?
|
| Renal Dialysis | 1 | 2018 | 889 | 0.090 |
Why?
|
| Kidney Failure, Chronic | 1 | 2018 | 915 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2018 | 6601 | 0.080 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 3752 | 0.060 |
Why?
|
| United States | 1 | 2019 | 11752 | 0.050 |
Why?
|
| Adult | 4 | 2020 | 31958 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2012 | 3182 | 0.040 |
Why?
|
| Choroid Diseases | 1 | 2019 | 23 | 0.040 |
Why?
|
| Biomarkers | 2 | 2020 | 3432 | 0.040 |
Why?
|
| Animals | 1 | 2021 | 36524 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2009 | 3997 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2020 | 333 | 0.040 |
Why?
|
| Papilledema | 1 | 2019 | 87 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2018 | 34 | 0.040 |
Why?
|
| Osmolar Concentration | 1 | 2018 | 179 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 298 | 0.030 |
Why?
|
| Vision Disorders | 1 | 2019 | 221 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 399 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2020 | 616 | 0.030 |
Why?
|
| Spinal Puncture | 1 | 2015 | 53 | 0.030 |
Why?
|
| Adolescent | 2 | 2015 | 20581 | 0.030 |
Why?
|
| Intraocular Pressure | 1 | 2015 | 136 | 0.030 |
Why?
|
| ROC Curve | 1 | 2015 | 611 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 2994 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 3415 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 2195 | 0.020 |
Why?
|
| Time Factors | 1 | 2020 | 6604 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 7207 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 9912 | 0.010 |
Why?
|